# Nestle divests peanut allergy business Palforzia
Author:  Pal Sinha,Barnali
Author URL: https://fintechherald.com/author/pal-sinha-barnali
Published: 2023-09-04
Category: Headlines
Category URL: https://fintechherald.com/category/headlines
Meta Title: Nestle divests peanut allergy business Palforzia to
Meta Description: Nestle has divested its peanut allergy treatment business Palforzia to Stallergenes Greer, a biopharmaceutical company specializing in allergies. Nestle will
URL: https://fintechherald.com/nestle-divests-peanut-allergy-business-palforzia

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsh86i001bwirgpt97g904/images/2023-09-04t052527z1lynxmpej8302vrtroptp4aimmune-nestle-stake-1736847664519-compressed.jpg)

## Nestle divests peanut allergy business Palforzia   ZURICH (Reuters) – Nestle has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic review of the division.    Nestle said it has offloaded Palforzia to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of allergies.    Nestle will receive milestone payments and ongoing royalties from Stallergenes Greer, it said.        (Reporting by John Revill, Editing by Friederike Heine)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---